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Abstract
Peroxisome proliferator-activated receptor gamma coactivator-1a (PGC-1a) is a transcriptional coactivator involved in the regulation
of mitochondrial biogenesis and cell defense. The functions of PGC-1a in physiology of brain mitochondria are, how-
ever, not fully understood. To address this we have studied wild-type and transgenic mice with a two-fold overexpres-
sion of PGC-1a in brain neurons. Data showed that the relative number and basal respiration of brain mitochondria
were increased in PGC-1a transgenic mice compared with wild-type mitochondria. These changes occurred concomi-
tantly with altered levels of proteins involved in oxidative phosphorylation (OXPHOS) as studied by proteomic analyses
and immunoblottings. Cultured hippocampal neurons from PGC-1a transgenic mice were more resistant to cell degen-
eration induced by the glutamate receptor agonist kainic acid. In vivo kainic acid induced excitotoxic cell death in the
hippocampus at 48 h in wild-type mice but significantly less so in PGC-1a transgenic mice. However, at later time
points cell degeneration was also evident in the transgenic mouse hippocampus, indicating that PGC-1a overexpres-
sion can induce a delay in cell death. Immunoblotting showed that X-linked inhibitor of apoptosis protein (XIAP) was
increased in PGC-1a transgenic hippocampus with no significant changes in Bcl-2 or Bcl-X. Collectively, these results
show that PGC-1a overexpression contributes to enhanced neuronal viability by stimulating mitochondria number and
respiration and increasing levels of OXPHOS proteins and the anti-apoptotic protein XIAP.
Introduction
Mitochondria are important for producing cellular energy in the
form of ATP via the process of oxidative phosphorylation. In addi-
tion, mitochondria are involved in regulation of cell metabolism, in
the production of oxidative free radicals and in the control of intra-
cellular calcium and of the intrinsic (mitochondria-dependent) path-
way for cell death (Danial & Korsmeyer, 2004; Lindholm et al.,
2004; Cascone et al., 2012; Nunnari & Suomalainen, 2012). Mito-
chondrial dysfunctions are observed during the course of several
neurodegenerative diseases such as Parkinson0s disease (PD; Lin &
Beal, 2006; Rugarli & Langer, 2012; Nunnari & Suomalainen,
2012). It has been proposed that boosting the number and functions
of mitochondria can be beneﬁcial in counteracting cell degeneration
occurring in brain diseases (Houten & Auwerx, 2004; Handschin &
Spiegelman, 2006).
Peroxisome proliferator-activated receptor-c coactivator-1a (PGC-
1a) is a master regulator of mitochondrial biogenesis and cell viabil-
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ity (Austin & St-Pierre, 2012; Mudo et al., 2012) and plays a role
in the pathogenesis of PD and in Huntington’s disease (Cui et al.,
2006; St-Pierre et al., 2006; Weydt et al., 2006; Zheng et al.,
2010). The precise mechanisms by which PGC-1a mediates neuro-
protection are not fully understood. In addition to mitochondria,
PGC-1a may inﬂuence cell signaling pathways, possibly in a cell-
and tissue-speciﬁc manner.
In the present work, we have studied the role of mitochondria and
PGC-1a in the control of neuronal viability using a model of excito-
toxic brain injury caused by kainic acid (KA; Olney et al., 1974;
Korhonen et al., 2001; Condorelli et al., 2002). KA acts through
KA–glutamate receptors on neurons causing neuronal damage particu-
larly within speciﬁc regions in the hippocampus (Lerma, 2006). We
studied hippocampus from wild-type and PGC-1a transgenic (tg)
mice with overexpression of the transgene in neurons under the neu-
ron-speciﬁc promoter Thy1 (Caroni, 1997; Trapp et al., 2003). We
have previously shown that the midbrain dopaminergic neurons in the
PGC1-tg mice are signiﬁcantly protected against the deleterious
effects of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyri-
dine (MPTP) in the mouse model of PD (Mudo et al., 2012). Using
functional proteomics we analyzed the expression of mitochondrial
proteins and how they might be changed by overexpression of PGC-
1a in the brain neurons. The results showed that several proteins
involved in oxidative phosphorylation (OXPHOS) were increased in
the PGC-1a-tg mouse brain as compared to wild-type animals. In
addition, the number and basal oxidative capacity of brain mitochon-
dria were increased in the PGC-1a-tg mice.
Materials and methods
Animals
PGC-1a-tg mice expressing full-length PGC-1a with a Flag-tg in
brain neurons were genotyped and bred in our animal house as
described before (Mudo et al., 2012). Experiments were approved
by the ethical committees at the University of Helsinki and the
University of Palermo and carried out in accordance with the Euro-
pean Communities Council Directive (86/609/EEC). Three-month-
old male wild-type and PGC-1a-tg mice were injected with KA
(Sigma, St Louis, MO, USA) into the lateral ventricle (0.35 lg/lL)
in a volume of 0.5 lL as described (Sokka et al., 2007; Putkonen
et al., 2011). Controls received equal volume of saline, and mice
were killed at different times after injections. Wild-type and PGC-
1a-tg mice were decapitated under deep anesthesia, and brains were
rapidly dissected, frozen in isopentane, cooled in liquid nitrogen and
stored at 70 °C until analysis. The right side of the brain was used
for histology and the left for immunoblots.
TdT-mediated dUTP nick-end labeling (TUNEL) and Fluoro-
Jade staining
TUNEL labeling and Fluoro-Jade staining were performed essen-
tially as described previously (Korhonen et al., 2001, 2005; Sokka
et al., 2007). In brief, for TUNEL labeling hippocampal sections
from wild-type and PGC-1a-tg mice treated with KA or vehicle
were ﬁxed for 10 min with acetone : methanol (1:1) at 20 °C.
The sections were then permeabilized with 0.1% Tween-20 and 1%
bovine serum albumin in phosphate-buffered saline on ice. Fluores-
cein-labeled UTP (Roche, Basel, Switzerland) was added and sec-
tions incubated for 1 h at +37 °C, washed and analyzed under a
ﬂuorescence microscope (Zeiss, Germany). Hoechst staining (1 mg/
mL, no. 33342; Sigma) was used to label cell nuclei. For Fluoro-
Jade (0.001%; Histochem, Jackson, AR, USA) staining (Schmued
et al., 1997; Korhonen et al., 2001; Chidlow et al., 2009) the
sections were immersed for 5 min in 1% sodium hydroxide in 80%
ethanol, rinsed for 2 min in 70% ethanol, and then rinsed in distilled
water. Potassium permanganate solution (0.06%) was added for
10 min, followed by a 10-min incubation in 0.0001% Fluoro-Jade C
(Chemicon; Merck Millipore, Darmstadt, Germany). After staining,
sections were washed in distilled water and mounted with Vec-
tashield ﬂuorescein-mounting medium (Vector Laboratories, Burlin-
game, CA, USA). The number of Fluoro-Jade- and TUNEL-positive
cells was counted at the same bregma level in wild-type and treated
mice (n = 4–8 for each time point).
Cresyl violet staining
For staining, mice were perfused with 4% paraformaldehyde in phos-
phate-buffered saline as described (Mudo et al., 2012). Brains were
dissected, dehydrated and embedded in parafﬁn using standard proce-
dures. 10 lm brain sections from wild-type and PGC-1a-tg mice
were dehydrated in an alcohol series, rehydrated in distilled water
and stained in 0.3% Cresyl violet solution (Kebo, Sweden) for 15 s.
Sections were rinsed in distilled water followed by an alcohol series,
mounted with Entellan (Kebo) and analyzed using light microscopy
(Korhonen et al., 2005; Putkonen et al., 2011).
Immunohistochemistry
For immunohistochemistry, 5-lm hippocampal sections from
bregma 4.30 to 6.50 mm from control and PGC-1a-tg mice were
obtained using a microtome (Microm HM240E; Thermo Scientiﬁc,
Waltham, MA, USA) and collected on microscope slides. The slides
were dried, deparafﬁnized and rehydrated in an alcohol series and
water as above. For antigen retrieval, slides were heated in 10-mM
citric acid solution at pH6 in a microwave oven for 5 min three
times. Following three short washing steps, slides were incubated
for 1 h with phosphate-buffered saline with 5% bovine serum albu-
min (Sigma) and 0.1% Triton-X-100 at room temperature. Primary
PGC-1a (1:200; number ST1202; Merck Millipore, Billerica, MA,
USA) and NeuN (1:300; MAB377; Merck Millipore) antibodies
were then added overnight at +4 °C, followed by secondary Alexa
488- or 594-conjugated antibodies (1:500; Invitrogen, ThermoFisher,
Waltham, MA, USA). Control samples were without primary anti-
bodies. To label nuclei, Hoescht (Sigma) blue staining was used.
Quantitative PCR (qPCR)
Total RNA was extracted using the RNeasy lipid tissue kit (Qiagen,
Hilden, Germany), followed by cDNA synthesis using Superscript
VILO cDNA synthesis kit (Invitrogen) as described (Do et al.,
2012; Hyrskyluoto et al., 2013). qPCR ampliﬁcation was performed
using a Light Cycler 480 II instrument (Roche Diagnostics, Basel,
Switzerland) as described (Do et al., 2012; M€akel€a et al., 2014).
Reactions were run in 96-well-plate format in a ﬁnal volume of
10 ll and were optimized for maximal accuracy of quantiﬁcation.
The PCR reaction mixture contained 2 lL cDNA and 100 lM for-
ward (F) and reverse (R) primers in 19 SYBR Green Master mix
(Roche). The reaction was carried out at 95 °C for 10 min followed
by at 95 °C for 15 s, 60 °C for 20 s and 72 °C for 10 s using 40
cycles. Each sample was run in triplicates on a 96-well plate and
water was used as negative control. Expression levels were calcu-
lated based upon the 2–DDCT method using reference genes for b-
actin and GAPDH that gave similar results. Primers used were:
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PGC-1a: F, 50-CAAACCAACAACTTTATC-30 and R, 50-TAGTCT
TGTTCTCAAATG-30; b-actin: F, 50-CCTTCTTGGGTATGGAAT
C-30 and R, 50-TGTTGGCATAGAGGTCTT -30; GAPDH: F,
50-CGACTTCAACAGCAACTC-30 and R, 50-TATTCATTGTCA
TACCAG-GAA-30.
Mitochondrial DNA copy number
DNA was isolated from wild-type and PGC-1a-tg mice using
QIAamp DNA Mini Kit (Qiagen) according to the manufacturer’s
protocol. The relative mitochondrial DNA (mtDNA) copy number
was measured using qPCR comparing the ratio of mtDNA to
nuclear DNA as described before (Ylikallio et al., 2010). In brief,
the mitochondria-encoded cytochrome-b (cytB gene) was used for
mtDNA and b-actin gene for nuclear DNA quantiﬁcation. The pri-
mer sequences used were: for cytB, F, 50-GCTTTCCACTTCATCT-
TACCATTTA-30 and R, 50-TGTTGGGTTGTTTGATCCTG-30; for
b-actin: F, 50-CCACCATGTACCCAGGCATT-30 and R, 50-
ATCCCTGC-TTGCTGATCCAC-30. The PCR reaction mixture con-
tained 25 ng DNA and 100 nmol/L of F and R primers in 19
SYBR Green Master mix (Roche). The reaction was carried out at
95 °C for 10 min, then 40 cycles at 95 °C for 10 s and 60 °C for
30 s. Each sample was run in triplicate on a 96-well plate and water
was used as negative control. qPCR ampliﬁcation was performed
using a Light Cycler 480 II instrument (Roche) as described
(M€akel€a et al., 2014). The ratio of mtDNA to nuclear DNA reﬂects
the relative concentration of mtDNA.
Neuronal cultures
Hippocampal neurons were prepared from embryonic day (E)18
mouse from wild-type and PGC1-tg mice, and plated on poly-
DL-ornithine (Sigma)-coated 96-well plates at a density of
40 9 103 cells. Cells were cultured in Neurobasal medium con-
taining 2% B27 as described previously (Korhonen et al., 2001;
Sokka et al., 2007; Kairisalo et al., 2009; Putkonen et al., 2011).
Different concentrations of KA were added to the cultures for
24 h to induce cell degeneration (Korhonen et al., 2001). Cell
viability was determined by the MTT [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide assay (Sigma) as described
previously (Korhonen et al., 2001; Sokka et al., 2007; Reijonen
et al., 2010; Hyrskyluoto et al., 2013). The assays were per-
formed three times or more.
Calcium imaging
Hippocampal neurons plated on poly-DL-ornithine-coated 25-mm
cover glasses were incubated with 4 lM fura-2 acetoxymethylester
(Molecular Probes Invitrogen, Life Technologies Ltd, Paisley, UK)
at 37 °C for 20 min in HEPES-buffered media (pH 7.4) consisting
of (in mM): NaCl, 137; KCl, 5; KH2PO4, 0.44; NaHCO3, 4.2;
CaCl2, 1; MgCl2, 1; HEPES, 10; and glucose, 10 (all from Sigma-
Adlrich). After incubation the cover glass was used as the bottom
of an open 1-mL chamber as previously described (Louhivuori
et al., 2015). Using 340- and 380-nm light excitation ﬁlter chang-
ers under the control of the InCytIM-2 System (Intracellular Imag-
ing Inc., Cincinnati, OH, USA) and a dichroic mirror (DM430;
Nikon), light emission was measured through a 510-nm barrier ﬁl-
ter with an integrating charge-coupled device camera (COHU Inc.,
Poway, CA, USA). A ratioed image of the ratio 340 : 380 nm was
acquired each second. The data collected was analyzed with the
InCyt 4.5 software (Intracellular Imaging Inc.) and further pro-
cessed with Origin 6.0 software (OriginLabCorp, Northhampton,
MA, USA).
Isolation of brain mitochondria and analyses of respiratory
capacity
Mitochondria were isolated from brain tissue of wild-type and PGC-
1a-tg mice as previously described (Speer et al., 2003; Mudo et al.,
2012). Oxygen consumption measurements of isolated mitochondria
were performed as described (Rogers et al., 2011) with minor modi-
ﬁcations. Mitochondria were suspended in a medium containing (in
mM): sucrose, 250; Hepes-KOH pH 7.4, 10; EGTA, 1; Mg2+, 3; Pi,
3; D-b-hydroxybutyrate, 5; and pyruvate, 5; the mitochondria were
dispensed onto a Seahorse 96-well plate (Seahorse Bioscience, Bos-
ton, MA, USA) at a concentration of 40 lg protein per well. Mito-
chondria were sedimented by centrifugation at 2000 g for 20 min at
+4 °C. The oxygen consumption rate (OCR) of mitochondria was
determined in real-time using the Seahorse XFe96 analyzer (Sea-
horse Bioscience) as previously described (M€akel€a et al., 2014).
ADP (1 mM) was added to the wells prior to the start of the experi-
ment followed by the addition of 1 lM carbonyl cyanide 4-(triﬂuoro-
methoxy)phenylhydrazone (FCCP; mitochondrial uncoupler) and
1 lM rotenone (complex I inhibitor of the respiratory chain) plus
1 lM antimycin A (complex III inhibitor). Three measurements were
done for each experimental condition, and experiments were
repeated. The values obtained were normalized to the amount of
mitochondrial protein determined in each sample.
Western blotting
Immunoblotting was done essentially as described previously
(Korhonen et al., 2001; Sokka et al., 2007; Putkonen et al., 2011;
Hyrskyluoto et al., 2014). In brief, hippocampal tissue from wild-
type and PGC-1a tg mice was lysed using ice-cold RIPA buffer
(NaCl, 150 mM; Triton-X-100, 1%; sodium deoxycholate, 0.5%;
SDS, 1%; and Tris-HCl, pH 7.4, 50 mM) supplemented with pro-
tease inhibitor cocktail (Roche) and phosphatase inhibitors (PhoStop;
Roche). Equal amounts of protein were subjected to SDS-PAGE
and blotted onto nitrocellulose ﬁlters (Amersham Biosciences,
Bucks, UK), which were incubated for 1 h in 5% skimmed milk or
bovine serum albumin, in TBS-T (Tris-HCl, pH 7.5, 50 mM; NaCl,
150 mM; and Tween 20, 0.1%), and then with primary antibodies
overnight at 4 °C. These included antibodies against Bcl-2 (diluted
1:1000; Cell Signaling Technology, Denvers, MA, USA; cat number
28769), Bcl-xL (1:1000; BD Transduction Laboratories, Franklin
Lakes, NJ, USA; cat number B310211), GluR6/7 (1:1000; no. 04-
921; Millipore/Upstate, Merck Millipore), PGC-1a (1:2000; Merck,
Merck Millipore), X-linked inhibitor of apoptosis protein (XIAP;
1:5000; BD Biosciences, Franklin Lakes, NJ, USA) and b-actin
(1:1000, number 2066; Sigma). After washing, the ﬁlter was incu-
bated with horseradish peroxidase-conjugated secondary antibodies
(1:2500; Jackson ImmunoResearch Laboratories, West Grove, PA,
USA), followed by detection using enhanced chemiluminescence
(Thermo, Waltham, MA, USA). Quantiﬁcations were done using the
ImageJ software (version 1.410).
To study expression of respiratory change proteins we applied the
OXPHOS antibody cocktail (diluted 1:250; no. 110413; Abcam,
Cambridge, UK) for immunoblotting. This contains antibodies for
proteins of the ﬁve respiratory chain complexes (I-V). Anti-porin
antibody was used as a control. We further employed an antibody
against ATP synthase-5b (kind gift from B. Battersby) to compare
with data on ATP synthase-5a in complex V (Fig. 3).
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Proteomic analyses
Sample preparation and proteolytic digestion
Ten micrograms of protein from control and PGC-1a-tg mice brains
was digested using a modiﬁed FASP protocol (Scifo et al., 2015). In
brief, lysate buffer was exchanged by washing it several times with
8 M urea and 0.1 M Tris, pH 8 (urea buffer; UB). The proteins were
reduced by addition of 10 mM DTT in UB, washed, alkylated with
50 mM iodoacetamide in UB, and 1:50 w/w of lysine-C endopepti-
dase (Wako, Richmond, VA, USA) was added in ~ 4 M urea with
0.1 M Tris, pH 8, followed by incubation overnight at room tempera-
ture. The peptide digest was collected by centrifugation, and trypsin
solution was added in a ratio of 1:50 w/w in 50 mM ammonium
bicarbonate. The peptide digests were cleaned using C18 reverse-
phase ZipTipTM (Millipore), resuspended in 1% triﬂuoroacetic acid
and sonicated for 1 min in a water bath.
Liquid chromatography (LC)–high deﬁnition mass spectrometry
(HDMS)
Three-hundred nanograms of digested proteins (three technical repli-
cates per sample) was used for LC-MS analysis. The peptides were
separated with the nanoAcquity UPLC system (Waters) equipped
with a 5-lm Symmetry C18 trapping column, 180 lm 9 20 mm,
reverse-phase (Waters), followed by an analytical 1.7-lm,
75 lm 9 250 mm BEH-130 C18 reversed-phase column (Waters),
in a single-pump trapping mode. The injected sample was trapped at
a ﬂow rate of 15 lL/min in 99.5% of solution A (0.1% formic
acid), and the peptides were separated with a linear gradient of 3–
35% of solution B (0.1% each of formic acid and acetonitrile), for
100 min at a ﬂow rate 0.3 lL/min and a column temperature of
35 °C. The columns are ﬂushed with an additional 5-min wash with
up to 85% of solution B, followed by two empty runs to wash out
any remaining peptides. The randomized samples were run in ion
mobility-assisted data-independent analysis mode (HDMSE), in a
Synapt G2-S mass spectrometer (Waters), by alternating between
low collision energy (6V) and a high collision energy ramp (20–
45 V) in the transfer compartment and using a 1-s cycle time. The
separated peptides were detected online with a mass spectrometer,
operated in positive resolution mode in the range m/z 50–2000 amu.
Human [Glu1]-ﬁbrinopeptide B (150 fmol/lL; Sigma) in 50% ace-
tonitrile with 0.1% formic acid solution at a ﬂow rate of 0.3 lL/min
was used for a lock mass correction, applied every 30 s.
Database mining of LC-HDMSE
Relative quantiﬁcation between samples using precursor ion intensi-
ties was performed with TransOmicsTM Informatics for Proteomics
software (Nonlinear Dynamics, Waters) and ProteinLynx Global Ser-
ver (PLGS V3.0). MSE parameters were set as follows: low energy
threshold of 135 counts, elevated energy threshold of 30 counts, and
intensity threshold of precursor/fragment ion cluster 750 counts. To
compare the control(s) to other subjects we utilized the between-sub-
jects design scheme of TransOmicsTM software. The ANOVA calculation
applied by this scheme assumes that the conditions are independent
and applies the statistical test that presumes the means of the condi-
tions are equal. Database searches were carried out against the
reviewed Mus musculus UniProtKB-SwissProt database (release
2014_04; 32538 entries) with the Ion Accounting algorithm and the
following parameters: peptide and fragment tolerance, automatic;
maximum protein mass, 500 kDa; min fragment ion matches per pro-
tein, ≥ 7; min fragment ion matches per peptide, ≥ 3; min peptide
matches per protein, ≥ 1; primary digest reagent, trypsin; missed
cleavages allowed, 2; ﬁxed modiﬁcation, carbamidomethylation C;
variable modiﬁcations, phosphorylation of STY residues; oxidation of
methionine (M) and false discovery rate (FDR), < 4%. Protein quanti-
tation was performed entirely on non-conﬂicting protein identiﬁca-
tions, using precursor ion intensity data and standardized expression
proﬁles. For annotation of mitochondrial protein expression we imple-
mented differential change in protein expression > 1.3-fold, ANOVA P
value < 0.05 and two or more unique peptides for quantitation. The
annotation of mitochondrial proteins was achieved with MitoMiner
v3.1_2014-08, an integrated web resource of mitochondrial pro-
teomics (http://mitominer.mrc-mbu.cam.ac.uk/). The MitoMiner data-
base combines evidence for mitochondrial involvement derived from
the MitoMiner Reference Set (all species, 12925 proteins), the Mito-
Carta Inventory (human and mouse, 2682 proteins), IMPI (Integrated
Mitochondrial Protein Index) v.Q3_2014 (human, mouse, rat and
cow, 6726 proteins), annotations from Gene Ontology cellular compo-
nent, information from large-scale mass-spectrometry studies and
mitochondrial targeting sequence predictions. In the ﬁnal steps of the
procedure we manually curated the datasets based on literature knowl-
edge. The mitochondrial proteins were further analyzed using Ingenu-
ity Pathways (www.ingenuity.com). Data on the mitochondrial
protein changes are given in Table S1 and alterations in OXPHOS
protein levels in Fig. 3.
Quantiﬁcation and statistical analysis
Statistical comparisons were performed using one-way ANOVA fol-
lowed by Bonferroni post hoc tests. Immunoreactive cells were
counted in the hippocampus after KA injections using the public
domain NIH image program (http://rbs.info.nih.gov/nih-image).
Brains were analyzed and, for each animal, ﬁve non-overlapping areas
within the dentate gyrus and the CA1 and CA3 regions of the hip-
pocampus were counted. Values are expressed as mean  SEM. For
each time-point analyzed in vivo, 4–8 mice were used. Evaluation of
the staining intensity per cell was done using the ImageJ Software.
Student’s unpaired t-test was used for comparing immunoblots
and neuronal cultures from wild-type and PGC-1a-tg mice. Experi-
ments were repeated more than three times. P ≤ 0.05 was consid-
ered signiﬁcant. Values are expressed as mean  SEM.
For proteomic analyses, differentially regulated pathways were
calculated as described above and P-values corrected using the mul-
tiple-testing Benjamin–Hochberg procedure.
For annotation of mitochondrial protein expression, we implemented
a differential change in protein expression of > 1.3-fold, ANOVA
P-value < 0.05 and two or more unique peptides for quantitation.
Results
Characterization of tg PGC-1a-expressing mice
Using the neuron-speciﬁc Thy1 promoter (Caroni, 1997; Trapp et al.,
2003) we generated mice with overexpression of PGC-1a in brain
neurons (Mudo et al., 2012). We have previously shown that the mid-
brain dopaminergic neurons in these mice are less vulnerable to treat-
ment with neurotoxins such as MPTP (Mudo et al., 2012).
Transgenic expression using the Thy1 promoter can vary between
different neuronal populations (Caroni, 1997) so we characterized the
expression of PGC-1a in brain cortex and hippocampus of PGC-1a-tg
mice. Quantitative PCR showed that the PGC-1a mRNA levels were
increased about two-fold in hippocampus and brain cortex in PGC-
1a-tg mice compared with wild-type animals (Fig. 1A). Furthermore,
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Fig. 1. PGC-1a is expressed in neurons in hippocampus and brain cortex of tg mice. (A) qPCR was performed using cDNA made from hippocampus (HC)
and brain cortex (CX) of 3-month-old wild-type and PGC-1a-tg mice. Note a two-fold increase in PGC-1a expression in the tg mice compared with wild-type
animals. Values are means  SEM; n = 4, ***P < 0.001. (B) Immunoblotting using tissue lysates of HC and CX of wild-type and PGC-1a-tg mice. PGC-1a
is shown as a band at 100 kDa and was increased in the PGC-1a-tg mice. A typical experiment is shown and this was repeated with similar results. (C) Sec-
tions were made from hippocampus of wild-type and PGC-1a-tg mice and immunostained using anti-PGC-1a antibodies. Upper panels, anti-PGC-1a (red ﬂuo-
rescence) antibodies were combined with anti-NeuN (green ﬂuorescence) antibodies as a marker for neurons. Merged pictures (yellow) show co-staining of
PGC-1a and NeuN in neurons in the CA3 region of hippocampus. Lower panels, anti-PGC-1a antibody (green ﬂuorescence) was combined with Hoescht blue
staining as a marker for nuclei. PGC-1a was present in most of the cell nuclei in the CA3 region. Scale bars, 100 lm (upper), 50 lm (lower).
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the protein levels of PGC-1a were substantially increased in the
PGC-1a-tg mice (Fig. 1B). To study the expression of PGC-1a at the
cellular level, we performed double staining using anti-PGC-1a and
anti-NeuN antibodies, the latter being a marker for neurons. Data
showed that PGC-1a is expressed by neurons in the CA3 area of hip-
pocampus in PGC-1a-tg and wild-type hippocampus (Fig. 1C). The
calculated relative intensity of staining using the anti-PGC-1a anti-
body was signiﬁcantly increased in hippocampal (1.25  0.001,
***P < 0.001, n = 4) and in cortical (2.96  0.008, ***P < 0.001,
n = 4) neurons in PGC-1a-tg mice compared with wild-type animals.
Immunolabeling of PGC1a combined with Hoescht blue staining
revealed that PGC-1a is mainly nuclear; however, some immunoreac-
tivity was also observed in the cytoplasm of neurons (Fig. 1C). This
may reﬂect a possible regulatory step in PGC-1a physiology in neu-
rons that requires mores studies in the future.
Mitochondrial number and oxidative respiration are increased
in brains of PGC1-tg mice
PGC-1a plays a major role as an activator of mitochondrial biogene-
sis and cell viability (Houten & Auwerx, 2004; Handschin & Spiegel-
man, 2006; Austin & St-Pierre, 2012). We therefore studied the
relative number of mitochondria in brains tissue of wild-type and
PGC-1a-tg mice using qPCR (see Materials and Methods). Data
showed that the content of mtDNA was increased in hippocampus in
PGC-1a-tg mice compared with corresponding wild-type animals
(Fig. 2A). We then studied the functions of mitochondria isolated
from brain of wild-type and PGC-1a-tg mice using the Seahorse
XFe96 analyzer. A graph from these experiments presented in
Fig. 2B shows that the mitochondria from PGC-1a-tg mice had a
higher basal OCR than did wild-type animals (Fig. 2B). The values
obtained were normalized to the amount of mitochondrial protein and
indicated that brain mitochondria in PGC-1a-tg mice are functionally
more efﬁcient than those in the wild-type animal using this assay.
This result corroborates previous data showing an increased respira-
tion of brain mitochondria in PGC-1a-tg mice (Mudo et al., 2012).
Analyses of mitochondrial proteins in brains of PGC-1a-tg mice
To investigate protein changes in PGC-1a-tg mice in more detail,
we performed functional proteomics analyses using mass spectrome-
try combined with bioinformatics, with a focus on mitochondrial
proteins (see Materials and Methods). Canonical pathway analyses
using Ingenuity Pathways and differentially expressed mitochondrial
proteins (Table S1) pinpointed the mitochondrial dysfunctions and
oxidative phosphorylation as being the statistically most associated
pathways. Results showed that the relative abundance of several res-
piratory chain proteins involved in OXPHOS was altered in the
PGC-1a-tg brain cortex as compared to wild-type cortex (Fig. 3A).
The inset in Fig. 3A shows representative proteins of mitochondrial
complex I (NDUFA10), complex II (SDHB), complex IV (COX5A)
and complex V (ATP synthase-5I, -O and -8 proteins) that are
increased in PGC-1a-tg brain cortex.
To validate our ﬁndings, we performed immunoblotting using iso-
lated mitochondria from wild-type and PGC-1a-tg mice. The levels
of SDHB in complex II and cytochrome c oxidase subunit I in com-
plex IV were signiﬁcantly increased in the PGC-1a-tg mouse mito-
chondria compared with wild-type mice (Fig. 3A and B). The
changes in OXPHOS proteins in complex II were less evident using
the antibodies available, whereas the level of NDUFB8 appeared to
be decreased in the PGC-1a-tg mouse mitochondria (Fig. 3A and
B). Proteomic analyses on whole brain cortex demonstrated dysregu-
lation in expression of several subunits of the ATP synthase in the
mitochondrial complex V, in the PGC-1a-tg brain (Table S1). With
the antibodies against the ATP synthase subunits 5a and 5b
(ATP5A1 and ATP5B; Fig. 3B) we observed a trend for upregula-
tion of these components. Thus the mass spectrometric measure-
ments revealed a similar increase in relative abundance, P < 0.05;
not shown).
Taken together, these results show that neuronal overexpression
of PGC-1a affects the expression of OXPHOS proteins in the brain,
which affects the mitochondrial bioenergetics in these cells. Our
proteomic analyses also revealed that proteins other than the
OXPHOS ones were altered in the brains of PGC-1a-tg mice, some-
thing that is probably of functional signiﬁcance for control of
neuronal viability.
PGC-1a protects against KA-induced excitotoxicity in vitro with
no change in GluR6 receptors or intracellular calcium levels
Neurons are sensitive to cell degeneration induced by excessive
stimulation of glutamate receptors occurring in epilepsy and other
Fig. 2. Mitochondrial number and capacity are altered in PGC1-tg mouse brain. Three-month-old wild-type and PGC-1a-tg mice were used for analyzing the
number and respiratory function of mitochondria as described. (A) DNA was isolated from brain tissue and mtDNA copy number was analyzed using qPCR.
The relative mtDNA copy number was increased in brains of PGC-1a-tg compared with wild-type mice. Values are means  SEM; n = 3, *P < 0.05. (B)
Mitochondria were prepared from brain cortex of wild-type and PGC-1a-tg mice. OCR by mitochondria was measured in real-time using the Seahorse XFe96
equipment. There was an increase in the basal OCR in PGC-1a-tg mitochondria compared with wild-type ones. Values are means  SEM; n = 6, *P < 0.05
for PGC-1a-tg mice vs. wild-type.
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neurological disorders (Coyle & Putfarcken, 1993; Choi, 1994;
Mattson, 2003). KA stimulates a speciﬁc class of glutamate recep-
tors (GluRs) (Lerma, 2006), leading to neuronal cell death in hip-
pocampus and some other areas of the brain (Olney et al., 1974;
Condorelli et al., 2002). To study whether the overexpression of
PGC-1a inﬂuences the cell responses towards KA we prepared hip-
pocampal neurons from PGC-1a-tg and wild-type mice and cultured
the cells for 7 days prior to KA treatment. Incubation of cells for
24 h with 10–100 lM KA increased cell death of hippocampal neu-
rons from wild-type mice in a concentration-dependent manner
(Fig. 4A) that is in line with previous data with rat hippocampal
neurons (Korhonen et al., 2001). In contrast, hippocampal neurons
isolated from PGC-1a-tg mice were largely resistant to cell degener-
ation induced by KA (Fig. 4A). However, at a higher (300 lM) con-
centration of KA, hippocampal neurons from PGC-1a-tg mice also
succumbed to cell death, indicating that the protection against exci-
totoxicity was not absolute.
To investigate whether the expression of the KA-responsive
GluR, GluR6, is altered in the hippocampus we performed immuno-
blots using a speciﬁc antibody for this receptor (Putkonen et al.,
2011). Data showed that there was no difference in the levels of
GluR6 in hippocampus between wild-type and PGC-1a-tg mice
using an antibody recognizing both GluR6 and GluR7 subtypes of
glutamate receptors (Fig. 4B). This suggests that the neuroprotection
afforded by PGC-1a is not reﬂected by an altered level of GluR6/7.
We then studied whether intracellular calcium levels are differen-
tially increased by KA in neurons from wild-type and PGC-1a-tg
mice. Fig. 4C and D shows that KA equally increased calcium
levels in wild-type and PGC-1a-overexpressing neurons. It is still
possible, however, that subtle differences may occur in calcium han-
dling in these cells, particularly with regard to mitochondria or
endoplasmic reticulum. This issue will require more details studied
of wild-type and PGC-1a overexpressing neurons in the future.
PGC-1a induces a partial neuroprotection against excitotoxic
neuronal damage in vivo
Next we studied changes in neuronal viability in vivo by injecting
KA into the brains of wild-type and PGC-1a-tg mice. Hippocampal
subregions, such as the C3 area, are particularly vulnerable to KA-
induced neuronal excitotoxicity, as also shown here by an increase
in the number of pycnotic cells revealed by Nissl staining (Fig. 5A).
Similar results were obtained by using Fluoro-Jade to analyze neu-
ronal degeneration (Korhonen et al., 2005; Sokka et al., 2007).
Thus, KA induced a signiﬁcant increase in Fluoro-Jade labeling in
the CA3 region of wild-type mice at 48 h post-injection but less of
an increase in PGC-1a-tg mice (Fig. 5B). However, at 72 h post-
injection cells in the CA3 region of PGC-1a-tg mice also became
labeled with Fluoro-Jade, a sign of ongoing cell degeneration. At
this time point the relative number of Fluoro-Jade-positive cells in
the CA3 and CA1 regions in PGC-1a-tg mice exceeded the corre-
sponding numbers observed in wild-type mice (Fig. 5C).
To corroborate our ﬁndings with Fluoro-Jade, we employed
TUNEL staining to detect DNA breaks as a marker of degenerating
and dying neurons. Data showed that the number of TUNEL-posi-
tive cells induced by KA increased to a maximum at 48 h in the
CA3 area of wild-type animals (Fig. 6A). In contrast, the number of
TUNEL-positive cells was much less in the CA3 area in the PGC-
1a-tg mice at this time point (Fig. 6A). At 72 h the number
TUNEL-positive cells was about equal in the CA3 area in PGC-1a-
tg and wild-type mice (Fig. 6A). In the CA1 region, the number of
TUNEL-positive cells was less than in the CA3 region and the
difference between PGC-1a-tg and wild-type mice was not as dra-
matic (Fig. 6B). In the dentate gyrus and hilus regions, few scat-
tered cells became TUNEL-positive in both wild-type and PGC-1a-
tg mice (Fig. 6C). These results on TUNEL labeling revealed a par-
tial protection of hippocampal neurons against KA excitotoxicity in
the PGC-1a-tg mice, particularly in the CA3 region. This is in
agreement with data on Fluoro-Jade labeling above, and shows that
neuronal degeneration induced KA was not totally abolished but
rather delayed in the PGC-1a-tg mice.
Expression of anti-apoptotic proteins in hippocampus of
control and PGC1-tg mice
In view of the protective effect observed with KA in the PGC-1a-
tg mice we analyzed the levels of some well-known cell survival
proteins in these animals. Western blotting revealed no signiﬁcant
changes in the levels of Bcl-2 and Bcl-xL in hippocampus of
PGC-1a-tg compared with wild-type mice (Fig. 7A and B). In
contrast, XIAP was signiﬁcantly increased in hippocampus of
PGC-1a-tg mice (Fig. 7C), suggesting that elevated XIAP may
mediate part of the neuroprotection. This ﬁnding is in line with
previous data on the roles of XIAP in KA-induced neurodegenera-
tion (Korhonen et al., 2001) and in brain ischemia (Trapp et al.,
2003).
Discussion
The present results show that overexpression of PGC-1a in brain
neurons leads to a partial protection against KA-induced neuronal
degeneration. This was shown by using Fluoro-Jade and by TUNEL
labeling to identify degenerating neurons in the hippocampus of
wild-type and PGC-1a-tg mice. TUNEL staining is a well-estab-
lished method for detection of DNA breaks in dying cells and Flu-
oro-Jade is widely used to reveal nerve cell degeneration (Schmued
Fig. 3. Proteomic and immunoblot analyzes of mitochondria and OXPHOS proteins in wild-type and PGC-1a-tg mice. (A) Proteomics. Upper panel, differen-
tially expressed mitochondria-associated proteins in brain cortex of wild-type and PGC-1a-tg mice were analyzed. Two canonical pathways are presented
(rectangle) with the highest predicted P-values (P-values were corrected using the multiple-testing Benjamin–Hochberg procedure): the mitochondrial dysfunc-
tion and OXPHOS pathways. Selected OXPHOS proteins are shown with proportional change values given in the inset. Lower panel, OXPHOS proteins in
complexes II, IV and V were upregulated in PGC-1a-tg brain cortex, as shown by the arrows. COX5A, cytochrome c oxidase subunit 5A; SDHB, succinate
dehydrogenase (ubiquinone) iron-sulfur subunit; NDUFA10, NADH dehydrogenase [ubiquinone] 1 a subcomplex subunit 10; ATP5O, ATP synthase subunit O;
ATP5I, ATP synthase subunit e, mitochondrial; ATP8, ATP synthase protein 8. (B) Immunoblots. Expression of mitochondrial OXPHOS proteins was analyzed
by immunblotting using an antibody cocktail against speciﬁc proteins in the complex I-V (CI-V). Anti-porin antibody was used as a control. NDUFB8, NADH
dehydrogenase (ubiquinone) 1b subunit 8 in CI; SDHB, succinate dehydrogenase in CII; UQCRC2, ubiquinol-cytochrome c reductase complex core protein in
CIII; MTCO1, cytochrome c oxidase catalytic subunit 1 in CIV; ATP5A, ATP synthase subunit 5a in CV. Left panel, immunoblot with short exposure showing
data on CII and CV. Immunoblot using an antibody against ATP synthase subunit 5b was also included. Right panels, immunoblot with longer exposure shows
data on CIII, CIV and CI. (C) Quantiﬁcation. Note increases in CII and CIV proteins in PGC-1a-tg mouse mitochondria compared with corresponding wild-
type. No signiﬁcant changes were observed for the CIII and CV proteins analyzed, whereas the NDUFB8 protein in CI was decreased as shown by the immu-
noblots. Values are means  SEM; n = 3, **P < 0.01.
© 2016 Federation of European Neuroscience Societies and John Wiley & Sons Ltd
European Journal of Neuroscience, 43, 626–639
632 J. M€akel€a et al.
Positive z-score
Mitochondrial dysfunction
Oxidative phosphorylation
TCA cycle II (Eukaryotic)
Remodeling of epithelial adherens junctions
GDP-glucose biosynthesis
Glucose and glucose-1-phosphate degradation
Huntington’s disease signaling
Induction of apoptosis by HIV1
Parkinson’s signaling
0.0 0.1 0.2 0.3 0.4 0.5 0.6
Ratio
0.7 0.8 0.9 1.0 1.1
Glutamine biosynthesis I
z-score = 0
0 1 2 3 4 5 6 7 8 9 10 11 12
–log(B-H P-value)
13 14 15 16 17 18 19 20
Negative z-score
Threshold
RatioNo activity pattern availableA
B
C
1,495
1,701
6,515
1,817
1,505
1,755
© 2016 Federation of European Neuroscience Societies and John Wiley & Sons Ltd
European Journal of Neuroscience, 43, 626–639
PGC-1a counteracts neuronal degeneration in hippocampus 633
et al., 1997; Korhonen et al., 2001; Chidlow et al., 2009), although
the precise substrate for this compound in neurons is not fully char-
acterized. In this study these two methods overlapped with respect
to changes in the number and spatial and temporal distribution of
degenerating neurons in hippocampal subﬁelds, with the largest
KA-induced changes observed in the CA3 area of wild-type ani-
mals.
Mitochondria are the major source of energy in the cell and neu-
ronal survival depends on proper function of these organelles (Lin
& Beal, 2006; Rugarli & Langer, 2012). PGC-1a plays a crucial
role in regulating biogenesis of mitochondria and cell protection
against oxidative and other types of stress (Puigsever & Spiegelman,
2003; St-Pierre et al., 2006). In the present work, we studied mech-
anisms for neuroprotection of PGC-1a-tg mice and attributed these
to changes in mitochondria with an increased relative number of
these organelles and with a higher basal capacity for oxygen con-
sumption.
Previous studies have shown that neurons in PGC-1a gene-
deleted mice are more vulnerable to oxidative stress and to neuro-
toxins such as KA and MPTP (St-Pierre et al., 2006). Along with
this we show here that increased PGC-1a expression in the PGC-
1a-tg mice afforded a substantial neuroprotection against the delete-
rious effects of KA, as studied in hippocampal neurons in vitro and
in vivo. This result substantiates previous data on the protective role
of tg-expressed PGC-1a in dopaminergic neurons in the mouse
model of PD (Mudo et al., 2012). Together, these studies support
the view that an increase in PGC-1a is beneﬁcial for promoting sur-
vival of neurons under stressful conditions by the neurotoxins. How-
Fig. 4. PGC-1a overexpression does not inﬂuence either GluR6 or changes in intracellular calcium in hippocampal neurons but does protect against KA-
induced cell damage. (A) Hippocampal neurons were prepared from embryonic day 18 wild-type and PGC-1a-tg mice. Cells were cultured for 7 days, followed
by the addition of increasing amounts of KA for 24 h. Cell viability was analyzed using the MTT assay. KA induced cell degeneration in a concentration-
dependent manner in wild-type neurons starting from 30 lM. PGC-1a-tg neurons were largely protected against KA, with a loss of cell viability at 300 lM KA.
Values are means  SEM; n = 3, ***P < 0.001, **P < 0.01 and *P < 0.05 for KA-treated vs. non-treated controls. (B) Immunoblots using hippocampal
lysates from wild-type and PGC-1a-tg mice using speciﬁc antibodies against GluR6/7. There was no signiﬁcant change in expression between these mice;
n = 4. (C and D) Calcium imaging using Fura-2. (C) A representative calcium imaging trace of a typical response towards increasing concentrations of KA.
(D) Statistics of the calcium response to different KA concentrations (0.1–100 lM). Quantiﬁcation. Total number of neurons analyzed: wild-type, 146 and PGC-
1a-tg, 141 in three different experiments. There was no signiﬁcant change in intracellular calcium at any concentration of KA used for treatment. Values are
means  SEM; n = 3.
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ever, as also shown here the neuroprotection induced by PGC-1a
against KA was not complete. Thus, cell degeneration of susceptible
neurons also occurred in the hippocampus of PGC-1a-tg mice, albeit
with a signiﬁcant delay. The reason for this is not clear at the
moment but could be due to the fact that the increases in mitochon-
drial number and viability were modest and not sufﬁcient for long-
term neuroprotection. KA is known to inﬂuence other pathways than
mitochondria that may contribute to cell death in neurons. In this
regard we have previously shown that KA induces changes in the
endoplasmic reticulum (ER) with increased ER stress causing neu-
ronal degeneration (Sokka et al., 2007). Increased cell degeneration
in the CA3 regions in PGC-1a-tg mice at later time points could
also be due to the overactivation by KA of other neuronal cells in
the brain, which in a circuit-dependent manner cause death of CA3
hippocampal neurons. It is further possible that the mode of cell
death changes with time such that necrotic pathways become more
prevalent at later time points and these are not rescued by mitochon-
dria. In favor of such an interpretation we noted that the staining
with Fluoro-Jade was still relatively high at 72 h post-treatment
compared with the corresponding number of TUNEL-positive cells
in the CA3 and CA1 regions of hippocampus (cf. Fig. 5A and B vs.
Fig. 4C). Whatever the underlying mechanisms, it seems that a two-
fold increase in PGC-1a mRNA is not enough to ensure complete
neuroprotection, at least in the context of excitotoxic injury. This
issue will require further studies with expression of higher levels of
PGC-1a in the neurons. However, it should also be taken into
account that a too high expression, as observed after viral delivery
of PGC-1a into brain tissue, can itself cause neuronal degeneration
(Ciron et al., 2012; Clark et al., 2012). These effects may be
explained by an overstimulation of mitochondria related to high
levels of PGC-1a and perhaps causing increased oxidative damage
(for a discussion see Lindholm et al., 2012). Hence it is pertinent to
study the optimal physiological levels of PGC-1a in neurons, and
how these can be attained by the use of drugs, substances and other
A
C
B
Fig. 5. PGC-1a affords neuroprotection against KA-induced exictotoxicity in vivo. Wild-type and PGC-1a-tg 3-month-old male mice were injected with KA
for different time periods. Controls received an equal volume of saline. Hippocampal sections were made at each time point and analyzed further as indicated.
(A) Nissl staining of hippocampal sections. Upper panels, whole hippocampus. Lower panels, higher magniﬁcation of the CA3 area. Note an increase in the
number of pycnotic nuclei (shown as dark points) in wild-type mice following KA. (B) Fluoro-Jade staining (green ﬂuorescence) shows cell degeneration in the
moue hippocampus. Time course of Fluoro-Jade staining in the CA3 area of the hippocampus: Fluoro-Jade-positive cells are present in wild-type mice at 48 h
but less so in PGC-1a-tg mice. The number of Fluoro-Jade-stained cells increased at 72 h in the PGC-1a-tg mice and decreased in the wild-type mice. (C)
Quantiﬁcation. The number of Fluoro-Jade-positive cells in the hippocampal subregions CA1, CA3 and DG were analyzed separately and counted. Values are
means  SEM; n = 3, ***P < 0.001, **P < 0.01 and *P < 0.05 for KA-treated vs. corresponding control saline; **P < 0.01 for 48 h KA-treated CA3 and
CA1 areas in wild-type mice vs. PGC-1a-tg mice. Scale bars, 1 mm (A, upper), 100 lm (A, lower), 75 lm (B).
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factors in order to achieve a beneﬁcial effect of PGC-1a in various
brain diseases.
As a transcriptional cofactor PGC-1a plays a role in the expres-
sion of various genes. We were therefore interested to study which
particular sets of proteins and particularly associated with mitochon-
dria are changed in the PGC-1a-tg mice. Using mass spectrometry
combined with bioinformatics tools we examined the mitochondria
proteome of wild-type and PGC-1a-tg mice. Data showed that par-
Fig. 6. TUNEL-labeled cells in the hippocampus of wild-type and PGC-1a-tg mice. Hippocampal sections were prepared from wild-type and PGC-1a-tg mice
after treatment with KA or saline for different times. TUNEL staining was analyzed in different hippocampal areas. (A) Upper panels. Representative images of
the time course of TUNEL labeling in the CA3 area of the hippocampus. Left, TUNEL-positive cells were present in wild-type mice at 48 h and less so in
PGC-1a-tg mice. Right, Hoechst staining was done to label nuclei. Lower panel. Quantiﬁcation shows the relative number of TUNEL-positive cells to Hoechst
blue-positive nuclei. Values are means  SEM; n = 3, ***P < 0.001, **P < 0.01 and *P < 0.05 for KA-treated vs. corresponding control saline; **P < 0.01
for 48 h KA-treated CA3 wild-type vs. PGC-1a-tg mice. (B) Number of TUNEL-positive cells in the CA1 region. Upper panel, representative images at 48 and
72 h after KA. Lower panel, quantiﬁcation as above. Values are means  SEM; n = 3, **P < 0.01 and *P < 0.05 for KA-treated vs. control saline. (C) The
number of TUNEL-positive cells in the dentate gyrus and hilus region. Upper panel, representative images at 48 h and 72 h after KA. Lower panel, quantiﬁca-
tion as above. Values are means  SEM; n = 3, *P < 0.05 for KA-treated vs. control saline. Scale bars, 50 lm.
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ticularly OXPHOS proteins were altered in PGC-1a-tg compared
with wild-type mice, but PGC-1a had a large effect on the
mitochondrial proteome in neurons. Of the respiratory proteins ana-
lyzed particularly SDHB in complex II and the cytochrome c oxi-
dase subunit I in complex IV were increased in PGC-1a-tg mice
(Fig. 3). This reﬂects the enhanced basal respiration in PGC-1a
mice overexpression in brain neurons. The present ﬁndings showing
alterations in mitochondrial proteins in the PGC-1a-tg mice comple-
ment previous studies on the role of PGC-1a in regulation of
OXPHOS proteins in brain tissue of PD patients (Zheng et al.,
2010). In addition to brain diseases, PGC-1a-regulated genes play
an important role in metabolic diseases including type 2 diabetes
(Mootha et al., 2003).
In contrast to SDHB, we observed that NDUFB8 in complex I
was downregulated in the PGC-1a-tg mice. This was also the case
for NDUFA4 but not for NDUFA10 (Table S1). Complex I is a
supramolecular complex composed of 45 protein subunits, and it is
possible that the various subunits are differentially regulated by
PGC-1a. Interestingly, it was recently shown that lower levels of
free complex I components can increase substrate utilization and
reduces production of oxygen free radicals during respiration (Miwa
et al., 2014). In view of this, the observed decreases in complex I
proteins may inﬂuence free radical production and contribute to an
increased resilience of neurons against toxin-induced cell death, but
this warrants more studies in the future.
Seizures induced by KA are known to alter intracellular pathways
related to induction of intracellular calcium and cell death (Korho-
nen et al., 2001; Belluardo et al., 2002; Mattson, 2003; Sokka
et al., 2007; Bozzi et al., 2011; Putkonen et al., 2011; Henshall &
Engel, 2013). KA acts via speciﬁc KA receptors such as GluR6/7
(Lerma, 2006; Putkonen et al., 2011). We therefore analyzed
whether the expression of GluR6/7 was altered by PGC-1a overex-
pression as a possible explanation for the neuroprotective effect
observed with PGC-1a. Data showed that there was no change in
GluR6/7 levels in hippocampus between wild-type and PGC-1a-tg
mice. In addition, imaging experiments revealed that KA induced a
similar increase in the intracellular calcium level in wild-type and
PGC-1a-tg neurons. These together indicate that the neuroprotection
afforded by PGC-1a against KA is not related to changes in the
GluR6/7 or in the calcium levels in the neurons.
In view of this we also studied the levels of anti-apoptotic pro-
teins in the hippocampus of wild-type and PGC-1a-tg mice. Among
the anti-apoptotic proteins, Bcl-2 and Bcl-xL belong to the Bcl-2
protein family and act at the level of the mitochondria to increase
cell survival (Adams & Cory, 1998; Korhonen et al., 2003),
whereas XIAP acts downstream of mitochondria to inhibit caspases
(Deveraux et al., 1997; Danial & Korsmeyer, 2004; Lindholm &
Arum€ae, 2004). We observed that the relative level of XIAP was
signiﬁcantly increased in the PGC-1a-tg mice compared with con-
trols, whilst Bcl-2 and Bcl-xL levels were not. We have previously
shown that tg expression of XIAP in brain neurons contributes to
neuroprotection after brain ischemia (Trapp et al., 2003; Fukuda
et al., 2004; Wang et al., 2004; Zhu et al., 2007). The present data
suggests that the increased levels of XIAP play a role in protecting
neurons against KA-induced cell degeneration in the hippocampus
in PGC-1a-tg mice. However, as discussed above, the neuroprotec-
tion in these animals was only partial, suggesting that the XIAP-
mediated cell survival is not sufﬁcient to fully block neuronal cell
death induced by KA. Likewise, XIAP overexpression failed to
completely protect against motoneuron degeneration observed in
mutant SOD1 mice as a model of familial amyotrophic lateral scle-
rosis (Wootz et al., 2006).
One intriguing question raised by this study is the mechanism by
which PGC-1a overexpression leads to elevation of XIAP. Previous
studies have shown that increases in XIAP are associated with NF-
jB signaling and oxidative stress regulation as well as with the
upregulation of brain-derived neurotrophic factor in neurons (Kairi-
salo et al., 2007, 2009, 2011). The issue is further complicated by
Fig. 7. Expression of anti-apoptotic proteins in the hippocampus of wild-type and PGC-1a-tg mice. Immunoblots using hippocampal lysates from wild-type
and PGC-1a-tg mice using speciﬁc antibodies as indicated. b-actin was used as control. Lanes 1-4, wild-type animals; lanes 5-8, PGC-1a-tg mice. Values are
means  SEM; n = 4, ***P < 0.001. (A and B) There were no signiﬁcant changes in the levels of (A) Bcl-2 or (B) BclxL between the groups. (C) XIAP was
signiﬁcantly increased in the PGC-1a-tg mice compared with wild-type animals.
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the notion that both transcriptional and posttranscriptional events
inﬂuence protein levels of XIAP, partially via enhanced protein
translation (Holcik et al., 2000). We are currently studying the links
between PGC-1a and other signaling pathways in hippocampal neu-
rons of PGC-1a-tg animals.
In this study we have overexpressed the full-length PGC-1a in brain
neurons of tg mice. Recent studies have observed the expression of
isoforms of PGC-1a in different tissues including brain (Soyal et al.,
2012). The presence of these variants were linked to the age of onset
of Huntington’s disease, but their precise functions remain to be deter-
mined. Moreover, brain-speciﬁc PGC-1a isoforms have so far been
described only for human brain tissue. It remains therefore to be stud-
ied whether these PGC-1a variants are also expressed in the mouse
brain and what their physiological function may be in neurons com-
pared with the canonical PGC-1a protein studied here.
In sum, we show here that tg expression of PGC-1a in brain neurons
induces a partial neuroprotection in mouse hippocampus against exci-
totoxic injury caused by KA. Increases in the relative number and res-
piratory functions of brain mitochondria contribute to the enhanced
neuronal viability. PGC-1a overexpression also elevated the anti-apop-
totic protein XIAP and increased the levels of particular OXPHOS pro-
teins in brain mitochondria. Our study of the time dependency also
revealed that the neuroprotection was not complete as PGC-1a overex-
pression induced a delay in nerve cell death in the hippocampus. This
is important and suggests that the modulation of PGC-1a expression
and mitochondria pathways in brain diseases are time-dependent and
should be combined with treatment strategies directed towards parallel
and other targets for intervention. In this respect the PGC-1a-tg ani-
mals can offer a suitable model for further studies of signaling path-
ways and protective mechanisms in brain diseases.
Supporting Information
Additional supporting information can be found in the online ver-
sion of this article:
Table S1. List of differentially expressed, mitochondria-associated
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